Biomedical Graduate Studies

Description of Clinical Expertise

Clinical Interests

General infectious diseases across the lifespan, travel medicine, and the prevention and management of infections in infants, children, and adults.

Keywords

Infectious diseases; pediatric infectious diseases; adult infectious diseases; travel medicine; vaccine-preventable diseases; congenital infections; perinatal infections; neonatal infections; maternal-fetal infections.

Clinical Details

Dr. Ross N. England is a physician specializing in infectious diseases who is fellowship-trained and board-certified in both adult infectious diseases and pediatric infectious diseases. He cares for both children and adults with a wide range of bacterial, viral, fungal, and parasitic infections in inpatient and outpatient settings.

In addition to general infectious diseases care, he provides pre-travel consultation and vaccination counseling for individuals and families traveling internationally, with a focus on prevention of travel-associated infections and vaccine-preventable diseases.

Dr. England has particular clinical interests in congenital and perinatal infections, as well as the prevention of infectious diseases through vaccination. These interests complement his research program studying maternal and infant immune responses to vaccines and the mechanisms by which maternal antibodies influence early-life immunity.

Description of Research Expertise

Research Interests

Understanding how maternal antibodies shape infant immune responses to vaccines and developing next-generation vaccine strategies that overcome maternal antibody interference in early life.

Keywords

Maternal antibody interference; neonatal immunity; early-life vaccinology; maternal immunization; mRNA vaccines; lipid nanoparticle vaccines; adjuvanted vaccines; influenza; measles; antibody epitope specificity; vaccine immunology.

Research Details

The England Laboratory studies how maternal antibodies influence infant immune responses to vaccination. Maternal IgG transferred during pregnancy protects newborns from infection but can also inhibit vaccine responses in early life, a phenomenon known as maternal antibody interference (MAI). This creates a major challenge for vaccines targeting pathogens that threaten infants during the first months of life.

Our research aims to define the immunologic mechanisms underlying MAI and identify vaccine strategies capable of overcoming this barrier. The laboratory combines approaches from immunology, vaccinology, and molecular biology to study how antibody epitope specificity, antibody affinity, and Fc-mediated immune regulation shape vaccine responses in early life.

Key areas of investigation include:

Mechanisms of epitope masking and Fc-mediated feedback in maternal antibody interference

How maternal antibody specificity influences the development of de novo infant antibody responses

The potential of mRNA-lipid nanoparticle and adjuvanted vaccine platforms to overcome maternal antibody inhibition

Experimental animal models of maternal antibody transfer and early-life vaccination

Ultimately, this work aims to inform the design of vaccines that can generate protective immunity in the presence of maternal antibodies, improving protection against infectious diseases during the vulnerable early months of life.